Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines - 19/04/17
![](/templates/common/images/mail.png)
Abstract |
Atopic dermatitis (AD) is a chronic pruritic inflammatory disease that commonly presents in the pediatric population. Although definitions and diagnosis of AD have largely been agreed upon, allergists and dermatologists have similar and divergent approaches to the management of AD. This review facilitated integration of the American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma & Immunology Joint Task Force 2012 AD Practice Parameter and the 2014 American Academy of Dermatology guidelines to highlight the basic principles of AD management and discuss therapies and management of AD from the distinct perspectives of the allergist and dermatologist.
Le texte complet de cet article est disponible en PDF.Key words : Atopic dermatitis, eczema, guidelines, Joint Task Force, American Academy of Dermatology, topical and systemic treatments
Abbreviations used : AAAAI, AAD, ACAAI, AD, JTF, MMF, TCI, TCS
Plan
Disclosure of potential conflict of interest: L. F. Eichenfield serves as a consultant for Allergan, Anacore/Pfizer, Galderman, Lilly, Otsuka/Medimetriks, TopMD, and Valeant; serves on the board for Valeant; and receives speakers' fees from Valeant. M. Boguniewicz receives personal fees from Omnia Education. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 139 - N° 4S
P. S49-S57 - avril 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?